Work

What are the benefits and harms of bisphosphonates, PTH or PTHrP analogues, denosumab, and romosozumab for preventing fractures in men, based on clinical trials?

Year: 2026
Type: article
Abstract: Current evidence highlights the benefits of interventions like denosumab and teriparatide in improving BMD and reducing fracture risk in men, although safety profiles, particularly cardiovascular risks with romosozumab, must be carefully managed.
Author: Tripdatabase
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7225996722
FWCI:
Cites:
Cited by:
Related to: 10